- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05700253
Comparing Pain Outcomes of Treatment Strategies for Osteoarthritis Knee Patients
Comparing Pain Outcomes of Cooled Radiofrequency Ablation and Hyaluronic Acid Therapies for Chronic Osteoarthritis Knee Patients
The goal of this clinical trial is to compare two different pain relief techniques (cooled radiofrequency ablation (CRFA) and hyaluronic acid (HA) injection) for patients with knee osteoarthritis (OA) over a period of 6 months. The main questions it aims to answer are:
- the extent of reduction of pain score and the proportion of subjects ("responders") whose knee pain is reduced by at least 50% from baseline up to 6 months after treatment in the two treatment groups.
- the safety of the two treatment modalities.
Participants will undergo a nerve block test to determine if they would experience pain relief from blocking of nerve signals. Responders will be randomised to receive one of the two treatments for their knee pain. Researchers will compare the pain intensity of CRFA and HA injection groups at baseline, 2 weeks, 1 month, 3 months and 6 months post-treatment using validated questionnaires.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study will be a single-centred, open-label, prospective randomized controlled study to compare the extent of OA-related knee pain relief between subjects who undergo radiofrequency lesioning (COOLIEF* CRFA; Avanos Medical) of the genicular nerves and subjects who receive a single intra-articular HA injection (Synvisc-One [Hylan G-F 20]; Sanofi). Study subjects will receive CRFA or HA injection in a 1:1 randomization scheme, with post-treatment data collection at 2 weeks, 1 month, 3 months and 6 months. Six months was chosen as the duration of follow-up as that is the expected duration of medical improvement following HA injection for chronic knee pain. Knee pain, function, overall subject impressions of treatment, quality of life, pain medication use, and adverse events will be compared among the treatment cohorts. The study is open-label as blinding is not possible due to the differences in administration of injection and CRFA, hence both the patient and the investigator will be aware of the treatment type.
The primary endpoints will be the extent of reduction of pain score measured via 11-point visual analogue scale (VAS). Secondary outcomes will include proportion of subjects ("responders") whose knee pain is reduced by at least 50% from baseline up to 6 months after treatment, patients' overall knee pain score as measured via Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), subjects' perception of treatment effect as measured via Knee injury and Osteoarthritis Outcome Score (KOOS), patients' perception of treatment effect via Global Perceived Effect (GPE) score and health related quality of life via EuroQol-5 Dimensions 5 Level (EQ-5D-5L). Assessments of these study endpoints will be made at baseline, 2 weeks, 1 month, 3 months and 6 months following treatment.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Seok Hwee Koo, PhD
- Phone Number: +6568504929
- Email: seok_hwee_koo@cgh.com.sg
Study Locations
-
-
-
Singapore, Singapore, 529889
- Changi General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age ≥ 21 years
- Able to understand the informed consent form and provide written informed consent and able to complete outcome measures
- Chronic knee pain for longer than 3 months that interferes with functional activities (for example, ambulation, prolonged standing, etc.)
- Continued pain in the target knee despite at least 3 months of conservative treatments, including activity modification, home exercise, protective weight bearing, and/or analgesics (for example, acetaminophen or non-steroidal anti-inflammatory drugs [NSAIDs] etc.)
- Positive response (defined as a decrease in numeric pain scores of at least 50%) to a single genicular nerve block of the index knee
- Pain on VAS ≥ 6 on an 11-point scale for the index knee
- Radiologic confirmation of arthritis (x-ray/MRI/CT) of OA grade of 2 (mild), 3 (moderate) or 4 (severe) noted within 6 months for the index knee
- An intra-articular HA injection is indicated as an appropriate treatment option
- WOMAC Knee Score group at baseline of Score of ≥ 2 (0 to 4 scale) on WOMAC question 1 (Pain) and a mean score of ≥ 1.5 on all five questions of the WOMAC pain subscale
- Agree to see one physician (study physician) for knee pain during the study period
- Willing to delay any surgical intervention for the index knee for the period of the study follow up
- Willing to comply with the requirements of this protocol for the full duration of the study
Exclusion Criteria:
- Evidence of inflammatory arthritis (for example, rheumatoid arthritis) or other systemic inflammatory condition (for example, gout, fibromyalgia) that could cause knee pain
- Evidence of neuropathic pain secondary to other causes (e.g., sciatica), apart from OA knee, affecting the index knee
- Previous or pending lower limb amputation
- Intra-articular steroid or PRP injection or Radiofrequency lesioning into the index knee within 180 days from randomization
- Hyaluronic acid injection, PRP injection, stem cell, or arthroscopic debridement/lavage injection into the index knee within 180 days from randomization
- Prior partial, resurfacing, or total knee arthroplasty of the index knee (residual hardware)
- Clinically significant ligamentous laxity of the index knee
- Clinically significant valgus/varus deformities or evidence of pathology (other than osteoarthritis of knee) that materially affects gait or function of the knee or is the underlying cause of the knee pain and/or functional limitations
- Body mass index (BMI) > 45 kg/m2 or < 18 kg/m2
- Extremely thin patients and those with minimal subcutaneous tissue thickness that would not accommodate a radiofrequency lesion of up to 14 mm in diameter to limit the risk of skin burns
- Pending or active compensation claim, litigation, or disability remuneration (secondary gain)
- Pregnant, nursing or intent of becoming pregnant during the study period
- Chronic pain associated with significant psychosocial dysfunction
- Patients with known psychiatric history including severe mental health issues.
- Allergies to any of the medications to be used during the procedures, including known hypersensitivity (allergy) to hyaluronate preparations or allergies to avian or avian-derived products (including eggs, feathers, or poultry)
- Active joint infection or systemic or localized infection at needle entry sites (subject may be considered for inclusion once infection is resolved)
- History of uncontrolled coagulopathy, ongoing coagulation treatment that cannot be safely interrupted for procedure, or unexplained or uncontrollable bleeding that is not correctable
- Identifiable anatomical variability that would materially alter the procedure as described in the protocol
- Within the preceding 2 years, subject has suffered from active narcotic addiction, substance, or alcohol abuse
- Current prescribed opioid medications greater than 60 milligrams morphine equivalent daily opioid dose
- Uncontrolled immunosuppression (e.g., AIDS, cancer, diabetes, etc.)
- Subject currently implanted with pacemaker, stimulator or defibrillator
- Participating in another clinical trial/investigation within 30 days prior to signing informed consent
- Subject unwilling or unable to comply with follow up schedule or protocol requirements
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Cooled Radiofrequency Ablation
Relieves pain by blocking pain signals via the deactivation of nerve structures using radiofrequency energy.
|
Image-guided genicular nerve ablation will be performed with the Coolief System (COOLIEF* CRFA; Avanos Medical).
|
Active Comparator: Hyaluronic Acid Injection
Injection of hyaluronic acid into the affected knee provides lubrication and shock absorption.
|
Synvisc-One ([Hylan G-F 20]; Sanofi) will be administered as a single intra-articular dose (6 mL).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Extent of reduction of pain score
Time Frame: 6 months
|
11-point Visual Analogue Scale
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of subjects ("responders") whose knee pain is reduced by at least 50% from baseline up to 6 months after treatment.
Time Frame: 6 months
|
11-point Visual Analogue Scale
|
6 months
|
Overall knee pain score
Time Frame: 6 months
|
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
|
6 months
|
Opinion of knee injury and treatment outcomes
Time Frame: 6 months
|
Knee injury and Osteoarthritis Outcome Score (KOOS)
|
6 months
|
Perception of treatment effect
Time Frame: 6 months
|
Global Perceived Effect (GPE) score
|
6 months
|
Health related quality of life
Time Frame: 6 months
|
EuroQol-5 Dimensions 5 Level (EQ-5D-5L)
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Prit Anand Singh, Changi General Hospital
Publications and helpful links
General Publications
- Wu L, Li Y, Si H, Zeng Y, Li M, Liu Y, Shen B. Radiofrequency Ablation in Cooled Monopolar or Conventional Bipolar Modality Yields More Beneficial Short-Term Clinical Outcomes Versus Other Treatments for Knee Osteoarthritis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Arthroscopy. 2022 Jul;38(7):2287-2302. doi: 10.1016/j.arthro.2022.01.048. Epub 2022 Feb 12.
- Oladeji LO, Cook JL. Cooled Radio Frequency Ablation for the Treatment of Osteoarthritis-Related Knee Pain: Evidence, Indications, and Outcomes. J Knee Surg. 2019 Jan;32(1):65-71. doi: 10.1055/s-0038-1675418. Epub 2018 Nov 5.
- Chen AF, Khalouf F, Zora K, DePalma M, Kohan L, Guirguis M, Beall D, Loudermilk E, Pingree MJ, Badiola I, Lyman J. Cooled radiofrequency ablation provides extended clinical utility in the management of knee osteoarthritis: 12-month results from a prospective, multi-center, randomized, cross-over trial comparing cooled radiofrequency ablation to a single hyaluronic acid injection. BMC Musculoskelet Disord. 2020 Jun 9;21(1):363. doi: 10.1186/s12891-020-03380-5.
- Chen AF, Khalouf F, Zora K, DePalma M, Kohan L, Guirguis M, Beall D, Loudermilk E, Pingree M, Badiola I, Lyman J. Cooled Radiofrequency Ablation Compared with a Single Injection of Hyaluronic Acid for Chronic Knee Pain: A Multicenter, Randomized Clinical Trial Demonstrating Greater Efficacy and Equivalent Safety for Cooled Radiofrequency Ablation. J Bone Joint Surg Am. 2020 Sep 2;102(17):1501-1510. doi: 10.2106/JBJS.19.00935.
- Lyman J, Khalouf F, Zora K, DePalma M, Loudermilk E, Guiguis M, Beall D, Kohan L, Chen AF. Cooled radiofrequency ablation of genicular nerves provides 24-Month durability in the management of osteoarthritic knee pain: Outcomes from a prospective, multicenter, randomized trial. Pain Pract. 2022 Jul;22(6):571-581. doi: 10.1111/papr.13139. Epub 2022 Jun 29.
Helpful Links
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Osteoarthritis01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
George Washington UniversityRecruitingCervical Fusion | Pain, Back | Pain, Neck | Myofacial PainUnited States
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Janssen Research & Development, LLCCompletedPain, Radiating | Pain, Burning | Pain, Crushing | Pain, Migratory | Pain, SplittingUnited States, France, Spain, Poland, Portugal
-
University of Campinas, BrazilCompletedPREGNANCY | LUMBAR BACK PAIN | PELVIC PAIN
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
Clinical Trials on Cooled Radiofrequency Ablation
-
Henry Ford Health SystemTerminatedChronic Knee PainUnited States
-
International Spine, Pain and Performance CenterHalyard HealthUnknownOsteo Arthritis Knee | Hip Osteoarthritis | Arthritis, Degenerative | Sacroiliitis | Arthritis;LumbosacralUnited States
-
Ziekenhuis Oost-LimburgBelgium Health Care Knowledge Centre; Klinische Epidemiologie en Medical Technology...RecruitingKnee Osteoarthritis | Chronic Knee Pain | Persistent Postsurgical PainBelgium, Netherlands
-
Hospital Son EspasesJosé Andrés López Riquelme; María del Pilar Sanchís CortésCompleted
-
University of UtahCompleted
-
Assiut UniversityNot yet recruitingOsteoarthritis, Knee
-
Northwestern UniversityAmerican Pain SocietyCompleted
-
Hospital General Universitario de ValenciaNot yet recruitingLow Back Pain, Recurrent | Neuropathic Pain | Mechanical Low Back Pain | Facet Joint Pain | Nociceptive Pain | Central Sensitisation | Aberrant Neuronal BranchingSpain
-
Avanos MedicalActive, not recruitingChronic Low-back PainUnited States
-
Avanos MedicalCompletedOsteoarthritis of the KneeUnited States